VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 788 filers reported holding VANECK VECTORS ETF TR in Q2 2024. The put-call ratio across all filers is 0.99 and the average weighting 0.4%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,165,410 | 69.82% |
| New Harbor Financial Group, LLC | 1,523,632 | $43,667,279 | 18.06% |
| Cadence Wealth Management LLC | 617,285 | $17,691,382 | 15.17% |
| Windmill Hill Asset Management Ltd | 798,150 | $22,874,979 | 14.71% |
| Slate Path Capital LP | 8,755,000 | $250,918,300 | 13.50% |
| SPX Gestao de Recursos Ltda | 3,997,000 | $114,554,020 | 12.37% |
| New Harbor Financial Group, LLC | 704,500 | $20,190,970 | 8.35% |
| Eschler Asset Management LLP | 150,000 | $4,299,000 | 8.15% |
| Hollow Brook Wealth Management LLC | 527,007 | $15,104,021 | 7.23% |
| Yong Rong (HK) Asset Management Ltd | 400,000 | $11,464 | 7.22% |